Polymorphisms of the AURKA (STK15/Aurora Kinase) Gene and Breast Cancer Risk (United States)
- 1 February 2006
- journal article
- research article
- Published by Springer Nature in Cancer Causes & Control
- Vol. 17 (1) , 81-83
- https://doi.org/10.1007/s10552-005-0429-9
Abstract
AURKA is an important protein in the regulation of G2 to M transition during mitosis. Due to this regulatory function, it has been hypothesized to be a potential cancer susceptibility gene. Two non-synonymous polymorphisms (F31I and V57I) have been associated with breast cancer risk in prior studies. We sought to confirm these findings in a large case control study nested within a prospective cohort, the Nurses' Health Study. Post-menopausal women who were homozygous for the 31I and 57V alleles had an increased risk of invasive breast cancer (OR 1.63, 95% CI 1.08–2.45). We also performed a meta-analysis to summarize the findings of this and prior studies of association between the F31I polymorphism and breast cancer risk (Summary OR 1.29, 95% CI 1.08–1.53, p-heterogeneity = 0.29). These results confirm prior findings that AURKA represents a low penetrance breast cancer susceptibility gene.Keywords
This publication has 6 references indexed in Scilit:
- Breast cancer risk associated with genotypic polymorphism of the mitosis‐regulating gene Aurora‐A/STK15/BTAKInternational Journal of Cancer, 2005
- STK15 polymorphism and breast cancer risk in a population-based studyCarcinogenesis: Integrative Cancer Research, 2004
- Functional Phe31Ile polymorphism in Aurora A and risk of breast carcinomaCarcinogenesis: Integrative Cancer Research, 2004
- Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and humanNature Genetics, 2003
- Centrosome aberrations: cause or consequence of cancer progression?Nature Reviews Cancer, 2002
- Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformationNature Genetics, 1998